Cancer Management
Standardized reviews of glioblastoma vascular patterns assist treatment choice
Published in Cancer Weekly, December 7th, 2004
"In a recent study, the existence of distinct vascular patterns with prognostic impact has been described in glioblastomas. The bizarre angiogenic subtype was associated with shorter postoperative survival times whereas the classic angiogenic subtype ('microvascular sprouting'; evenly distributed branching capillaries in major tumor parts resembling classic angiogenesis) was associated with a significantly more favorable outcome," researchers in Austria report.
"Evaluation of angiogenic subtypes of glioblastomas may be relevant for antiangiogenic therapy strategies,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-12-07)
More Articles from Cancer Weekly
- Breast Cancer
Topoisomerase II alpha is a prognostic indicator in breast cancer - Cervical Cancer
Study: Shorter, more aggressive treatments better control disease - Colon Cancer
Genetic markers of tumorogenic aberrant crypt foci identified - Renal Cancer
Dendritic cell-tumor fusion vaccines being developed for renal cell carcinoma - Renal-Cell Cancer
Allogeneic stem-cell transplantation for renal-cell cancer reviewed - Abortion
Corrections being made to Louisiana abortion brochure - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
